Sat Kartar Life gets trading approval for 50,400 preferential shares

1 min read     Updated on 08 Jul 2026, 11:23 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Sat Kartar Life Limited received NSE approval for the listing of 50,400 equity shares allotted to Non-Promoters via preferential issue. Trading began on July 07, 2026, with a lock-in period effective until January 29, 2027.

powered bylight_fuzz_icon
45035596

*this image is generated using AI for illustrative purposes only.

Sat Kartar Life has secured trading approval from the National Stock Exchange of India Limited (NSE) for 50,400 equity shares allotted to the Non-Promoters category on a preferential issue basis. The approval, conveyed via a letter dated July 06, 2026, allows these shares to be listed and admitted to dealings on the Exchange effective July 07, 2026. This development enables liquidity for the new shareholders, subject to regulatory lock-in requirements.

The allotment was conducted under Chapter V of the Securities and Exchange Board of India (Issue and Capital Disclosure Requirements) Regulations, 2018. While trading commences immediately, the shares are subject to a lock-in period until January 29, 2027, as mandated by the SEBI ICDR Regulations. This restriction ensures compliance with holding period norms for preferential allotments.

Details of the Allotment

The equity shares issued have a face value of ₹10 each. The specific details of the securities admitted to trading are outlined below:

Sr. No. Security Description Symbol Series No. of securities Distinctive Numbers
1. Equity shares of Rs. 10/- each issued under Preferential. SATKARTAR SM 50400 15744877 to 15795276

Lock-in Schedule

As per the regulatory framework, the newly issued shares are bound by a lock-in agreement. The schedule for these shares is as follows:

No. of Shares Distinctive Numbers Range Date upto which lock-in
From To
50400 15744877 15795276 29-Jan-2027

The company has disclosed that all relevant information regarding this preferential issue is available on its website. The NSE has also advised the company to utilize the NEAPS online filing facility for future submissions to ensure efficient processing.

Historical Stock Returns for Sat Kartar Life

1 Day5 Days1 Month6 Months1 Year5 Years
-0.93%-4.97%-16.42%-1.77%-21.61%-14.11%

How will the unlocking of 50,400 shares in January 2027 impact Sat Kartar Life's stock liquidity and share price?

What strategic initiatives will the company undertake with the capital raised from this preferential allotment?

Will the company pursue further equity dilution or preferential issues to fund future expansion?

Sat Kartar Life secures NABH accreditation valid till May 18, 2029

0 min read     Updated on 12 Jun 2026, 09:49 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Sat Kartar Life Limited has received NABH accreditation for its Paschim Vihar facility, valid until May 18, 2029, covering Panchakarma, Shalya Tantra, Naturopathy, and Yoga Treatments. This certification aims to enhance patient confidence and support future empanelments, reinforcing the company's commitment to quality healthcare standards.

powered bylight_fuzz_icon
42783558

*this image is generated using AI for illustrative purposes only.

sat kartar life has secured accreditation from the National Accreditation Board for Hospitals & Healthcare Providers (NABH) for its facility located at Paschim Vihar, New Delhi. The certification, valid until May 18, 2029, covers Panchakarma, Shalya Tantra, Naturopathy Treatments, and Yoga Treatments. This move is expected to strengthen the company's healthcare delivery platform and enhance patient confidence.

The accreditation was granted under certificate number AH-2026-0480. The update was submitted to the National Stock Exchange of India Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Accreditation Details

The following table outlines the scope of services and validity details for the accredited facility:

Location of Hospital Scope of Services Certificate No Valid upto
Sat Kartar Sanjeevan Hospital, Plot No. 18, Paschim Vihar Extension, New Delhi, Delhi 110063 Panchakarma, Shalya Tantra, Naturopathy Treatments, Yoga Treatments AH-2026-0480 May 18, 2029

The company stated that this recognition reinforces its commitment to quality standards in integrative healthcare and aligns with national best practices. The accreditation is also anticipated to support future empanelments with various healthcare bodies.

Historical Stock Returns for Sat Kartar Life

1 Day5 Days1 Month6 Months1 Year5 Years
-0.93%-4.97%-16.42%-1.77%-21.61%-14.11%

How will this NABH accreditation impact Sat Kartar Life's ability to secure new empanelments with insurance providers and government healthcare schemes?

Does the company plan to seek similar accreditation for its other facilities to standardize quality across its network?

What financial investments were required to meet NABH standards, and how will this affect the company's operational costs in the short term?

More News on Sat Kartar Life

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-21.61%